Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1994
Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse
B K Wershil, C M Theodos, S J Galli, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1989
Peptides encoded by the calcitonin gene inhibit macrophage function
Y H Nong, R G Titus, J M Ribeiro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 7, 1997
Recombinant human migration inhibitory factor has adjuvant activity
W Y Weiser, L M Pozzi, R G Titus, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
July 29, 1994
Saliva of Lutzomyia longipalpis sibling species differs in its composition and capacity to enhance leishmaniasis
A Warburg, E Saraiva, G C Lanzaro, et al.
Leprosy Review
|
December 1, 1986
Attempts to assess the contribution of T lymphocytes from the L3T4+ and LYT2+ subsets in the immunological control of cutaneous leishmaniasis
J A Louis, R G Titus, S C Mendonca, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 1986
Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice
G Milon, R G Titus, J C Cerottini, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 20, 1998
The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor
M B Soares, R G Titus, C B Shoemaker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 1995
Development of a safe live Leishmania vaccine line by gene replacement
R G Titus, F J Gueiros-Filho, L A de Freitas, et al.
Molecular and Biochemical Parasitology
|
October 1, 1993
Reversion to virulence in Leishmania major correlates with expression of surface lipophosphoglycan
A Shankar, T K Mitchen, L R Hall, et al.
Parasite Immunology
|
November 1, 1994
The effect of treating with anti-interleukin-1 receptor antibody on the course of experimental murine cutaneous leishmaniasis
C M Theodos, A Shankar, A L Glasebrook, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1994
Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse
B K Wershil, C M Theodos, S J Galli, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1989
Peptides encoded by the calcitonin gene inhibit macrophage function
Y H Nong, R G Titus, J M Ribeiro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 7, 1997
Recombinant human migration inhibitory factor has adjuvant activity
W Y Weiser, L M Pozzi, R G Titus, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
July 29, 1994
Saliva of Lutzomyia longipalpis sibling species differs in its composition and capacity to enhance leishmaniasis
A Warburg, E Saraiva, G C Lanzaro, et al.
Leprosy Review
|
December 1, 1986
Attempts to assess the contribution of T lymphocytes from the L3T4+ and LYT2+ subsets in the immunological control of cutaneous leishmaniasis
J A Louis, R G Titus, S C Mendonca, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 1986
Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice
G Milon, R G Titus, J C Cerottini, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 20, 1998
The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor
M B Soares, R G Titus, C B Shoemaker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 1995
Development of a safe live Leishmania vaccine line by gene replacement
R G Titus, F J Gueiros-Filho, L A de Freitas, et al.
Molecular and Biochemical Parasitology
|
October 1, 1993
Reversion to virulence in Leishmania major correlates with expression of surface lipophosphoglycan
A Shankar, T K Mitchen, L R Hall, et al.
Parasite Immunology
|
November 1, 1994
The effect of treating with anti-interleukin-1 receptor antibody on the course of experimental murine cutaneous leishmaniasis
C M Theodos, A Shankar, A L Glasebrook, et al.
Page
of 8